Sara Puente Marin

Publications

2023

Sara Puente Marin, Fabricia Dietrich, Peter Achenbach, Hugo Barcenilla, Johnny Ludvigsson, Rosaura Casas (2023) Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype Frontiers in Immunology, Vol. 14, Article 1112570 Continue to DOI

Sara Puente Marin, Per Hultman, Jimmy Ekstrand, Jesper Bo Nielsen, Said Havarinasab (2023) Secondary exposure to heavy metal in genetically susceptible mice leads to acceleration of autoimmune response Environmental Toxicology and Pharmacology, Vol. 104, Article 104317 Continue to DOI

2022

Christoph Nowak, Marcus Lind, Zdenek Sumnik, Terezie Pelikanova, Lia Nattero Chavez, Elena Lundberg, Itxaso Rica, Maria A. Martinez-Brocca, Mari Sol Ruiz de Adana, Jeanette Wahlberg, Ragnar Hanas, Cristina Hernandez, Maria Clemente-Leon, Ana Gomez-Gila, Marta Ferrer Lozano, Theo Sas, Stepanka Pruhova, Fabricia Dietrich, Sara Puente Marin, Ulf Hannelius, Rosaura Casas, Johnny Ludvigsson (2022) Intralymphatic GAD-Alum (Diamyd (R)) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2 Journal of Clinical Endocrinology and Metabolism, Vol. 107, p. 2644-2651 Continue to DOI

Rosaura Casas, Fabricia Dietrich, Sara Puente Marin, Hugo Barcenilla, Beatriz Tavira Iglesias, Jeanette Wahlberg, Peter Achenbach, Johnny Ludvigsson (2022) Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial) Acta Diabetologica, Vol. 59, p. 687-696 Continue to DOI

2021

Johnny Ludvigsson, Zdenek Sumnik, Terezie Pelikanova, Lia Nattero Chavez, Elena Lundberg, Itxaso Rica, Maria A. Martinez-Brocca, Marisol Ruiz de Adana, Jeanette Wahlberg, Anastasia Katsarou, Ragnar Hanas, Cristina Hernandez, Maria Clemente Leon, Ana Gomez-Gila, Marcus Lind, Marta Ferrer Lozano, Theo Sas, Ulf Samuelsson, Stepanka Pruhova, Fabricia Dietrich, Sara Puente Marin, Anders Nordlund, Ulf Hannelius, Rosaura Casas (2021) Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial Diabetes Care, Vol. 44, p. 1604-1612 Continue to DOI